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Abstract 
The effects of inflammatory c tokines (intedeukin-1/3, interleukin-6, and tumor necrosis factor-a) on energy metabolism were studied 
in primary cultured rat hepatocytes. Adenine nucleotide (ATP, ADP, and AMP) content, lactate production, the ketone body ratio 
(acetoacetate//3-hydroxybutyrate) reflecting the liver mitochondrial redox state (NAD+/NADH), and nitric oxide formation were 
measured. Insulin increased ATP content in hepatocytes and had a maximal effect after 8-12 h of culture. Both interleukin-1/3 and 
interleukin-6, but not tumor necrosis factor-a, significantly inhibited the ATP increase time- and dose-dependently. Intedeukin-1/3 and 
interleukin-6 also stimulated lactate production. During the same period, interleukin-1/3 but not intedeukin-6 decreased the ketone body 
ratio. Furthermore, interleukin-1/3 markedly stimulated nitric oxide formation in hepatocytes, and this increase was blocked by 
NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor) and by interleukin-1 receptor antagonist. NG-monomethyl-L-arginine 
reversed inhibition of the ATP increase, decrease in the ketone body ratio, and increase in lactate production, which were induced by 
intedeukin-1/3. Interleukin-1 receptor antagonist completely abolished all of the effects induced by intedeukin-1/3. These results 
demonstrated that interleukin-1/3 and interleukin-6 affect the insulin-induced energy metabolism in rat hepatocytes by different 
mechanisms. Specifically, interleukin-1/3 inhibits ATP synthesis by causing the mitochondrial dysfunction, a process which may be 
mediated by nitric oxide. 
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1. Introduction 
Inflammatory cytokines such as interleukin-1 (IL-1), 
interleukin-6 (IL-6) and tumor necrosis factor-a (TNFa) 
are detected in the plasma of patients with severe sepsis, 
and are known to induce a number of metabolic hanges 
[1]. Recent evidence has indicated that these cytokines play 
an important role in the regulation of energy metabolism in 
the liver. Infusion of TNFa and IL-1/3 causes drastic 
Abbreviations: IL- 1/3, interleukin- 1/3; IL- Ira, intedeukin- 1 receptor 
antagonist; IL-6, interleukin-6; KBR, ketone body ratio; L-NMMA, N G- 
monomethyl-L-arginine; NO, nitric oxide; TNFa, tumor necrosis factor-a. 
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alterations in carbohydrate and energy metabolism in rab- 
bits, and results in the reduction in hepatic mitochondrial 
pyruvate dehydrogenase activity, indicating the develop- 
ment of liver dysfunction [2]. In fact, TNFa is found to 
inhibit mitochondrial respiration in cultured rat hepato- 
cytes [3]. Pellicane et al. [4] reported that IL-1 receptor 
antagonist (IL-lra) preserves the level of ATP in mouse 
liver after hemorrhagic shock, suggesting that IL-1 is 
involved in the reduction in ATP levels during shock. 
Although ATP plays a critical role in the regulation and 
integration of cellular metabolism [5,6], few investigators 
have demonstrated a direct effect of inflammatory cy- 
tokines on ATP levels in the liver. Recently, we [7] have 
established a simple and rapid method for the assay of 
adenine nucleotides in rat and human cultured hepatocytes, 
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where it is found that the cells maintain a high level of 
ATP contents during the culture. The ketone body ratio 
(KBR; acetoacetate//3-hydroxybutyrate) is also a useful 
parameter to find out the mitochondrial function, because 
it reflects the mitochondrial redox state (NAD+/NADH) 
[81. 
In hepatocytes, a mixture of cytokines (IL-1/3, TNFot 
and interferon- 7) and lipopolysaccharide markedly aug- 
mented induction of nitric oxide (NO) synthase mRNA 
and NO formation, but any single cytokine or lipopoly- 
saccharide alone did not cause a significant NO formation 
[9-11]. NO, a highly reactive free-radical gas, plays a 
major role in a diverse array of physiological functions 
such as the regulation of vascular tone, neurotransmission 
and the mediation of immune responses [12-14]. NO 
inhibits the mitochondrial electron transport chain (com- 
plex I and II) [15,16] and the Krebs cycle enzyme aconi- 
tase, in target cells [17]. 
In this study, we investigated the effect of the inflam- 
matory cytokines, IL-1/3, IL-6, and TNFct, on cellular 
levels of ATP in primary cultured rat hepatocytes. Further- 
more, we examined the effects of the cytokines on the 
KBR, lactate production, and NO formation to elucidate 
mechanisms involving the regulation of ATP levels by 
cytokines. 
2. Materials and methods 
Materials. Human recombinant IL-1/3 was generously 
provided by Otsuka Pharmaceutical Co., Tokushima, Japan. 
IL-1/3 has a specific activity of 2 X 107 units/mg protein, 
and contains less than 1 ng of endotoxin per mg protein. 
Human recombinant IL-6 (5 × 10 6 units/mg protein) was 
generously provided by Ajinomoto Co., Yokohama, Japan. 
Human recombinant TNFa (2 X 106 units/mg protein) 
was purchased from Amersham International, Bucks, UK. 
L-NMMA, an NO synthase inhibitor [10], was obtained 
from Funakoshi Co., Tokyo, Japan. Human recombinant 
IL-lra [18], which is a competitive inhibitor of IL-1 activ- 
ity, was obtained from Pepro Tech Inc., New Jersey, USA. 
All other chemicals were of reagent grade. 
Culture of rat hepatocytes. Male Wistar strain rats (6-8 
weeks old, 200-280 g) fed ad libitum were used. All 
animals received humane care in accordance with the 
guidelines of the Animal Care Committee of Kansal Medi- 
cal University. Hepatocytes were isolated by perfusing the 
liver with collagenase under sterile conditions as described 
previously [19]. Hepatocytes, showing more than 80% 
viability by Trypan blue exclusion, were used for culture. 
Isolated hepatocytes were suspended in culture medium at 
5-6 X 105 viable cells/ml, seeded into plastic dishes (2 
ml per dish, 35 X 10 mm, Falcon Plastic, Oxnard, USA) 
and cultured as monolayers in a CO 2 incubator (under a 
humidified atmosphere with 5% CO 2 in air) at 37°C. The 
culture medium used was Williams' medium E (containing 
11 mM glucose) supplemented with 10% newborn calf 
serum, HEPES (5 mM), penicillin (100 units/ml), strepto- 
mycin (0.1 mg/ml), dexamethasone (10 -8 M), glucagon 
(2 X 10 - l° M) and insulin (10 -8 M). After 2-3 h of 
culture, the medium was replaced by fresh serum-free 
medium (1.5 ml/dish), and the cells were cultured for two 
days, with fresh medium supplied every day, and then used 
for experiments. The number of cells attached to the dishes 
was approx. 0.9 X 10 6 cells/dish, which was calculated 
from the number of cell nuclei by the method of Horiuti et 
al. [20]. The nucleus/cell ratio was 1.39 + 0.03 (mean + 
S.E.M., n = 14). The purity of the hepatocytes in culture 
was greater than 98% as determined by microscope obser- 
vation. 
Treatment of hepatocytes with cytokines. After removal 
of the culture medium, cultured hepatocytes were washed 
with 1 ml of Williams' medium E to remove hormones, 
and 1 ml of Williams' medium E supplemented with 5 
mM glucose (final concentration is 16 mM glucose) was 
added. Then, insulin (2.5 X 10 -8 M) was added to the 
medium in the presence or absence of cytokines (10 /xl in 
0.1% bovine serum albumin-saline) and cells were incu- 
bated in a CO 2 incubator. The final concentration f each 
cytokine in the incubation mixture was 10 -9 M, if not 
specified otherwise. IL-lra (10 -7 M) and L-NMMA (3.3 
X 10 -4 M) were added to the medium 15 min before each 
experiment. 
Miscellaneous. Adenine nucleotides (ATP, ADP and 
AMP) were measured by HPLC as reported previously [7] 
with minor modifications. Samples were prepared at 4°C 
or on ice. In brief, immediately after removal of the 
incubation medium, the cells were washed twice with 1 ml 
of saline and then 1 ml of 7% perchloric acid was added. 
Cells were scraped off the dish with a rubber policeman. 
After adjusting the pH to 6.0-6.5 with 2 M tripotassium 
phosphate (375 /xl), the cell lysate was centrifuged at 
10000 X g for 10 min. The supernatant was filtered (with 
a 0.45 /zm filter, type 13A Shimadzu Techno Research, 
Kyoto, Japan) and stored at -80°C until the assays were 
performed. A reverse-phase column (ODS-M 4.0 X 150 
mm, Shimadzu Techno Research) was used at a flow rate 
of 1 ml/min, with a buffer of 0.1 M ammonium dihydro- 
gen phosphate (pH 6.0), at a column temperature of 50°C. 
The injection volume was 40 /zl, and absorbance was 
monitored at 254 nm. ATP, ADP, and AMP were eluted 
with retention times of 2.19 min, 2.48 min, and 4.05 min, 
respectively. 
Ketone bodies (acetoacetate and /3-hydroxybutyrate) in 
the medium were measured enzymatically with a Ketorex 
kit (Sanwa Chemical, Nagoya, Japan) [21]. The KBR was 
calculated as acetoacetate//3-hydroxybutyrate. Lac ate in 
the medium was measured enzymatically with a commer- 
cial lactate assay kit (Boehringer Mannheim, Mannheim, 
Germany). 
Assay of NO formation. Accumulation of NO 2 and NO 
in the medium was considered to represent NO formation. 
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Fig. 1. Effect of inflammatory cytokines on the changes in ATP content 
in cultured rat hepatocytes. IL-lfl (A), IL-6 (ll), or TNFa (v )  were 
added to the incubation medium (Willams' medium E containing 16 mM 
glucose and 2.5× 10 -8 M) at a final concentration of 10 -9 M and 
incubated for the times indicated. Vehicle (0.1% bovine serum albumin in 
saline) was added to the control ((3). lntracellular ATP content was 
measured as described in Section 2. The ATP increase was calculated by 
subtracting basal ATP content at time 0 (16.90_+ 1.92 nmol/106 cells) 
from the value obtained for each experiment a the indicated times. Data 
are represented asmean _+ S.E.M. of 4 separate xperiments. * P < 0.01 
vs. control. 
The culture medium (250 /zl) was mixed with saturated 
ascorbic acid solution (2 ml) for 10-15 s in an enclosed 
tube, to reduce NO 2 to NO. Levels of NO in the medium 
were then determined with a redox chemiluminescence 
analyzer (FES-450, Scholar Tec, Osaka, Japan) [22,23]. 
Sodium nitrite was used in the generation of a standard 
curve for the measurement of NO. 
Statistical analysis of data. Statistical significance was 
analyzed by the unpaired Student's t-test, and P < 0.05 
was considered significant. Data are presented as the mean 
+ S.E.M. Error bars are omitted when they were within 
the size of the graphic symbol used. 
3. Results 
Effect of cytokines on intracellular ATP contents in rat 
hepatocytes. As shown in Fig. 1, insulin augmented intra- 
cellular ATP content in hepatocytes time-dependently with 
the maximal increase occurring at 8-12 h after its addition. 
The increase in ATP content at 12 h was 5.62 + 1.28 
nmol/106 cells (0 time, 16.90 _ 1.92; 12 h, 22.52 + 2.17 
nmol/106 cells; mean _ S.E.M., n = 4). Basal ATP con- 
tent in the absence of insulin (with 16 mM glucose) 
remained unchanged uring the incubation period (data not 
shown). Both IL- l f l  (10 -9 M) and IL-6 (10 -9 M) inhib- 
ited the insulin-induced ATP increase in a similar manner 
and maximal inhibition (50-70%) occurred at 12 h. TNFa 
(10 -9 M),  however, had no effect on the increase in ATP 
content. Table 1 shows the intracellular content of ATP, 
ADP, and AMP, and shows the energy charge in the 
Table 1 
Effect of cytokines on adenine nucleotide content in cultured rat hepato- 
cytes 
Cytokine Adenine nucleotides (nmol/106 cells) 
(10 -9 M) ATP ADP AMP Energy charge 
Control 21.5+0.7 2.9+0.3 0.5+0.1 0.92+0.01 
IL-1/3 18.1+0.3 * 2.9+0.6 0.5+0.1 0.91+0.01 
IL-6 18.1+0.4 * 2.7+0.4 0.5+0.1 0.91_+0.02 
TNFa 20.7_+ 1.3 2.9_+0.4 0.4_+0.0 0.92_+0.01 
ATP, ADP and AMP levels after 12 h of incubation, energy charge = 
(ATP + 1/2ADP)/(ATP + ADP + AMP). 
Data are represented asmean + S.E.M. of 4 separate xperiments. 
* P < 0.01 vs. control. 
presence and absence of various cytokines at 12 h. IL-1/3 
and IL-6 significantly decreased intracellular ATP content. 
Neither IL-1/3, IL-6, nor TNFa altered the amount of 
ADP or AMP. Similarly, these cytokines had no effect on 
the energy charge. Fig. 2 shows the dose-dependent in- 
hibitory effect of IL-1/3 and IL-6 on the increase in 
intracellular ATP. Concentrations for the half-maximal and 
maximal effects of IL- l f l  were approx. 3 X 10 -11 M and 
10 -9 M, respectively. IL-6 showed exactly the same 
dose-dependency as IL-1/3, for the inhibition of the in- 
crease in ATP. The effective doses observed for IL-1/3 
and IL-6 are in agreement with previous observations that 
cytokines act in picomolar concentrations order through 
specific high-affinity cell surface receptors [1]. 
Effect of cytokines on the KBR and lactate production. 
Fig. 3 shows the effect of cytokines on the KBR. The KBR 
is calculated as acetoacetate//3-hydroxybutyrate, that is 
directly proportioned to the mitochondrial free 
NAD+/NADH.  Although the KBR gradually declined 
with times in all groups, only IL-1/3 significantly de- 
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Fig. 2. Dose dependency of the inhibitory effects of IL- l fl and IL-6 on 
the increase inATP content in cultured rat hepatocytes. Hepatocytes were 
incubated with various concentrations f IL-1/3 (0) or IL-6 (O) for 12 h 
and ATP content was measured as described in Section 2. The ATP 
increase in the control (without IL- 1/3 ) was 5.18 + 0.64 nmol/106 cells 
(mean -+ S.E.M., n = 4) and was calculated as 100%. Data are repre- 
sented as mean + S.E.M. of 4 separate experiments. 
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Fig. 3. Effect of inflammatory cytokines on the KBR (KBR is calculated 
from the number of ketone bodies accumulated inthe medium of cultured 
hepatocytes) (a) over the total incubation time, or (b) over a given period 
of time during incubation. Hepatocytes were incubated with 10 -9  M 
IL-1/3 (A), IL-6 (hatched square), TNFa (hatched inverted triangle), or 
vehicle (O) as described in the legend for Fig. 1. Ketone bodies, 
acetoacetate and /3-hydroxybutyrate, were measured as described in 
Section 2 and the KBR was calculated as acetoacetate//3-hydroxy- 
butyrate. Data are represented asmean SEM of four dishes in one of the 
four experiments giving the similar results. * P < 0.01 vs. control. 
creased the KBR when compared with the control, at 8 and 
12 h (Fig. 3a). Hepatocytes cannot utilize ketone bodies as 
energy substrates, and ketone bodies subsequently accumu- 
late in the medium. Thenffore, the KBR was calculated 
from the quantity of  ketone, bodies accumulated for a given 
period of  t ime (0 -4 ,  4 -8 ,  and 8 -12  h, respectively) to 
clarify the effect of  IL-1 fl on the KBR. IL-1/3 had no 
significant effect on the KBR during the first 4 h of  
incubation, but the KBR decreased signif icantly after 4 -8  
h of  incubation (control 0.89 and IL-1/3 0.56). This de- 
crease was similar in magnitude to that observed after 
8 -12  h, suggesting that the IL-1/3 effect peaked after 4 -8  
h (Fig. 3b). As shown in 'Fable 2, 1L-l/3, but not IL-6 or 
TNFoa increased /3-hydroxybutyrate formation. None of 
Table 2 
Effect of cytokines on ketone body formation in cultured rat hepatocytes 
Cytokine 
(10 -9 M) 
Ketone bodies (nrr,ol/10 6 cells) 
Acetoacetate ~-Hydroxybutyrate KBR 
Control 160.9+ 1.4 126.9+ 1,0 1.28+0.01 
IL-1/3 155.7+1.2 157.6+1.0 * 0.99+0.01 * 
IL-6 175.1+2.7 133.7+2.0 1.31+0.01 
TNFa 162.1 + 1.9 133.0+0.8 1.23+0.02 
Acetoacetate and /3-hydroxybut3~rate lev ls after 12 h of incubation. 
KBR = acetoacetate//3-hydroxybutyrate. 
Data are represented as mean :t: S.E.M. of 4 dishes in one of the 4 
experiments giving similar resuh:s. 
* P < 0.01 vs. control. 
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Fig. 4. Dose dependency of the effects of IL-1/3 and IL-6 on the KBR in 
cultured rat hepatocytes. Hepatocytes were incubated with various con- 
centrations of IL-1/3 (0)  or IL-6 (O) for 12 h. The KBR was calculated 
as acetoacetate//3-hydroxybutyrate. Data are represented as mean+ 
S.E.M. of 4 dishes in one of the 4 experiments giving similar results. 
these cytokines, however,  had any effect on the formation 
of  acetoacetate. Thus, IL-1/3 increased the concentration 
of  /3-hydroxybutyrate (hence the decrease in the KBR). 
Furthermore, IL-1/3 decreased the KBR in a dose-depen- 
dent manner (Fig. 4). Concentrations of  IL- I  fl which 
induced half -maximal and maximal  effects were 10-  t 1 and 
10 -9 M, respectively, which is consistent with those con- 
centrations of  IL-1/3 which had an inhibitory effect on the 
insul in- induced ATP  increase (Fig. 2). Conversely,  IL-6 
had no effect on the KBR at the concentrations tested (up 
to 5 X 10 -9 M, Fig. 4). Treatment of  the cultured hepato- 
cytes with 2-tetradecylglycidic acid (2.5 × 10 -5 M), an 
inhibitor of  fatty acid /3-oxidation [24], did not affect 
ketone body formation or the KBR in either controls or 
IL-1/3-treated cells (data not shown), indicating that the 
IL-1/3 effect cannot be attributed to the activation of fatty 
acid r -ox idat ion in hepatocytes. IL-1/3 and IL-6 increased 
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Fig. 5. Effect of inflammatory cytokines on lactate production in cultured 
rat hepatocytes. Hepatocytes were incubated with IL-I/3 (A), IL-6 (11), 
or vehicle (O) as described in the legend for Fig. 1. Lactate in the 
medium was measured as described in Section 2. Data are represented as
mean S.E.M. of 4 dishes of 4 experiments. * P < 0.01 vs. control. 
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lactate production 1.29-fold and 1.16-fold respectively, 
when compared to the control at 12 h (Fig. 5). This effect 
of IL-1/3 showed the same dose-dependency that effects 
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on ATP content and the KBR demonstrated ( ata not 
shown). 
Blockage of IL-1/3 effects on energy metabolism by 
L-NMMA. Cytokines have been reported to stimulate NO 
formation in hepatocytes [9-11,25,26] and NO has been 
shown to inhibit the mitochondrial e ectron transport chain 
[15,16]. Because NO is one of the putative mediators of 
the various effects on energy metabolism which are in- 
duced by IL- I/3 and IL-6, we examined whether L-NMMA 
(an NO synthase inhibitor) inhibited the above-mentioned 
effects of IL-1/3 and IL-6. L-NMMA (3.3 × 10 -4 M)  
reversed the effect of IL-1/3 on ATP content, the KBR, 
and lactate production by 67%, 93%, and 58%, respec- 
tively (Fig. 6a-c). L-NMMA, however, did not alter the 
inhibitory effect of IL-6 on ATP content (Fig. 6a). These 
results suggest hat the effects induced by IL-1/3 may be 
mediated by NO. 
Effect of cytokines on nitric oxide formation. In order to 
examine whether IL- 1/3 induced NO formation in cultured 
hepatocytes, we measured NO in the cell culture media. As 
shown in Fig. 7, IL-1/3 markedly induced NO formation, 
but neither IL-6 nor TNFa did. The level of NO formation 
reached a maximum plateau at 12-16 h and was 50- to 
80-fold greater than control, with 10 -9 M IL-1/3 (EDs0 is 
3 × 10- ~ M, Kitade et al., manuscript in preparation). NO 
formation by IL-1/3 was more than 90% inhibited by 
L-NMMA (3.3 × 10 -4 M). 
Blockage of IL-1/3 effects on energy metabolism by 
IL-lra. IL-lra was used to confirm that IL-1/3 affected 
energy metabolism through the IL-I receptor [18]. The 
IL-lra (10 -7 M)  completely negated the effects of IL-1/3 
on ATP content, the KBR, lactate formation (Fig. 6a-c), 
and NO formation (Fig. 7). 
4. Discussion 
In the present study, IL-1/3 and IL-6, well-known in- 
flammatory cytokines, were shown to affect energy 
metabolism in primary cultured rat hepatocytes. IL-lfl 
inhibited the insulin-induced ATP increase (Figs. 1 and 2), 
decreased the KBR (Figs. 3 and 4), and stimulated lactate 
production (Fig. 5), in the same dose-dependent manner. 
Fig. 6. (a-c): Inhibition by L-NMMA and IL-lra of IL-lfl-induced 
effects on ATP content, the ketone body ratio and lactate formation. 
Hepatocytes were incubated with IL-lfl, IL-6, and vehicle (control) in 
the absence or presence of L-NMMA (3.3 × 10 -4 M) or IL-lra (10 -7 M) 
for 12 h. L-NMMA and IL-lra were added to the medium 15 min before 
the experiment. ATP content, the KBR, and lactate production were 
measured as described in Section 2. The basal evels for the ATP increase 
(a), the KBR (b), and for lactate production (c), were 5.85+0.57 
nmol/106 cells (calculated as 100%), 1.324-0.02, and 3.83-t-0.02 
/zmol/106 cells, respectively, at 12 h. L-NMMA and IL-lra did not alter 
these basal evels in the absence of IL-lfl. Data are represented asmean 
S.E.M. of 4 experiments. * P < 0.05 and * * P < 0.01 vs. IL-fl. 
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Fig. 7. Effect of inflammatory cytokines on NO formation in cultured 
hepatocytes. Hepatocytes were incubated with IL-1/3, IL-6, TNFa, vehi- 
cle (control), or with IL-1/3 in the presence of L-NMMA and IL-lra as 
described in the legend for Fig. 6. NO formation in the medium was 
measured as described in Section 2. The basal evel of NO formation was 
0.82×0.20 nmol/106 cells at 12 h. Data are represented asmean S.E.M. 
of 4 experiments. * P < 0.01 vs. control. 
For reasons mentioned below, the inhibition of ATP syn- 
thesis was hypothesized tobe mediated by NO via the IL-1 
receptor by the following pathway; IL-1/3 ~ IL-1 receptor 
increase of inducible NO synthase mRNA ~ NO for- 
mation ~ mitochondrial dysfunction ~ inhibition of ATP 
synthesis. This hypothesis was supported by the observa- 
tion that IL-lra completely blocked all of the effects 
induced by IL-lf l  (Figs. 6 and 7). In support of this 
observation, Kohira et al. [27] previously identified a 
biologically functional IL-1 receptor in primary cultures of 
rat hepatocytes. Furthermore, L-NMMA (an NO synthase 
inhibitor) not only blocked the induction of NO formation, 
but simultaneously blocked the decrease in the KBR, the 
inhibition of the insulin-induced ATP increase, and the 
stimulation of lactate production (Figs. 6 and 7). IL-1/3 
was also shown to markedly stimulate NO formation (Fig. 
7) and to induce NO synthase activity and the expression 
of NO synthase mRNA (Kitade et al., manuscript in 
preparation). IL-1/3 did not induce NO formation in cul- 
tured rat Kupffer cells under the same conditions used for 
hepatocytes (less than 1 nmol/106 cells of NO formation 
at 12 h). These observations eliminated the possibility that 
the NO formed in the cultured hepatocytes was derived 
from contaminating Kupffer cells (approx. 1-2% of the 
cells in our preparations). Finally, mitochondrial dysfunc- 
tion was confirmed by a decrease in the KBR and an 
increase in the lactate production. Because the decrease of 
KBR by IL-1/3 reflects a higher level of NADH, an initial 
substrate for oxidative phosphorylation, the inhibition of 
ATP synthesis by IL- 1/3 can be attributed to mitochondrial 
dysfunction. NO reportedly inhibits the Krebs cycle as 
well as the respiratory system at the level of the mito- 
chondria [15-17]. Therefore, the apparent increase in lac- 
tate production which was induced by IL-1/3 may be due 
to an inhibition of pyruvate ntry into the Krebs cycle. 
However, it is evident hat an NO-independent pathway is 
involved in the effects of IL-1/3, since L-NMMA only 
partially blocked the ATP inhibition (Fig. 6a) and lactate 
production (Fig. 6c) induced by IL-1/3. 
In contrast, IL-6 did not affect either the KBR (Fig. 3) 
or NO formation (Fig. 7), indicating that IL-6 inhibited the 
insulin-induced ATP increase through a pathway different 
from that of IL-1/3. Hotamisligil et al. [28] demonstrated 
that, in cultured adipocytes, IL-6, but not IL- 1/3, decreased 
insulin-stimulated autophosphorylation of the insulin re- 
ceptor and the phosphorylation of insulin receptor sub- 
strate 1, a major substrate of the insulin receptor in vivo. 
We found that IL-1/3 decreased basal levels of ATP but 
that IL-6 had no effect on the intracellular ATP content in 
the absence of insulin (unpublished observation). As such, 
IL-6 might directly interfere with insulin signaling through 
the insulin receptor, in hepatocytes. 
Adamson et al. [29] previously reported that TNFa at 
concentrations much higher (0.5 X 10 -7 M or more) than 
that employed here (10 -9  M) ,  drastically decreased intra- 
cellular ATP content (25% of control at 16 h) and stimu- 
lated NO formation 2- to 3-fold above control evels after 
isolated mouse hepatocytes were incubated for 24 h. They 
concluded that this inhibition of energy metabolism was 
due to the cytotoxicity of TNFa and was not related to NO 
formation. TNFa, however, affected neither energy 
metabolism nor NO formation at the lower concentration 
employed in our experiments (Fig. 1, Fig. 3, and Fig. 7). 
We have also observed that IL-I t~ had no significant 
effects on ATP increase and the KBR (data not shown). 
Consistent with our in vitro experiments, Evans et al. [30] 
reported that TNFa and IL-I a did not decrease hepatic 
ATP and the KBR in rats in vivo. 
In conclusion, IL-1/3 and IL-6 were shown to regulate 
energy metabolism in the liver. Furthermore, NO forma- 
tion was shown to be involved in the effects mediated by 
IL-1/3 but not those mediated by IL-6. The molecular 
mechanism for the inhibition of insulin-induced ATP syn- 
thesis, including intracellular signaling and the regulation 
of energy metabolism by IL-1/3 and IL-6 will be the 
subjects for further investigation. 
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